Kinde et al. analyzed uDNA from 76 patients with non-invasive urothelial carcinoma and showed that mutation in the TERT promoter region could be used as a biomarker for early detection of disease in patients being worked up for bladder cancer (11). Here, TERT is linked to urinary bladder carcinoma.